Personalized patient care starts with precision oncology.

Sophisticated diagnostic testing is how we enable you to deliver precision oncology to your patients. Our comprehensive testing menu of over 500+ tests encompasses all major testing methodologies – flow cytometry, FISH, cytogenetics, and targeted or broad-panel DNA- and RNA-based next-generation sequencing (NGS) – for tissue-based and liquid biopsy testing of solid tumour and hematologic cancers. NGS provides the resolution to detect targetable biomarkers and identify the driving mechanism behind your patient’s cancer, with the added benefit of revealing clinical trial opportunities and eligibility. Identifying the right test doesn’t have to be complicated. We simplify your ordering process with expertly designed single-order products, like The Oncomine™ Comprehensive Assay Plus – a unique offering that ranges from broad-spectrum pan-tumour profiling to disease-specific testing, harnessing the power of NGS.